CBD improves neuropsychiatric symptoms in tuberous sclerosis complex: EpiCom trial insights
Comments Off on CBD improves neuropsychiatric symptoms in tuberous sclerosis complex: EpiCom trial insights
April 21, 2026
The EpiCom trial highlights CBD neuropsychiatric symptoms tuberous sclerosis benefits beyond seizure control. This study provides evidence that CBD may improve behavioral and cognitive symptoms in TSC patients. These findings suggest new therapeutic…
Ozone Smog and Increased MS Risk in Children: Environmental Insights
Comments Off on Ozone Smog and Increased MS Risk in Children: Environmental Insights
April 8, 2026
This study highlights the link between air pollution autoimmune neurological conditions and increased risk of multiple sclerosis in children. It adds to evidence that environmental factors like ozone exposure may trigger autoimmune diseases. Clinicians…